These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 22961573

  • 1. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.
    Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR.
    Diabetes Care; 2013 Jan; 36(1):41-8. PubMed ID: 22961573
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
    Camilleri M, McCallum RW, Tack J, Spence SC, Gottesdiener K, Fiedorek FT.
    Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
    Andrews CN, Woo M, Buresi M, Curley M, Gupta M, Tack J, Wilsack L, Nasser Y.
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
    [Abstract] [Full Text] [Related]

  • 10. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
    Murray CD, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, Johnston C, Bloom SR, Emmanuel AV.
    Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
    [Abstract] [Full Text] [Related]

  • 11. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
    Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M.
    Regul Pept; 2008 Nov 29; 151(1-3):123-9. PubMed ID: 18675854
    [Abstract] [Full Text] [Related]

  • 12. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):847-53. PubMed ID: 16225494
    [Abstract] [Full Text] [Related]

  • 13. Effect of itopride on gastric emptying in longstanding diabetes mellitus.
    Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguère M, Horowitz M, Jones KL.
    Neurogastroenterol Motil; 2008 May 01; 20(5):456-63. PubMed ID: 18179609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J, Rotondo A, Meulemans A, Thielemans L, Cools M.
    Neurogastroenterol Motil; 2016 Apr 01; 28(4):487-97. PubMed ID: 27010235
    [Abstract] [Full Text] [Related]

  • 16. Extensive scintigraphic gastric motor function testing with concurrent symptom recording predicts prospectively measured daily dyspeptic symptoms.
    Wang XJ, O'Connor M, Peck T, Johnston G, Prichard DO.
    Neurogastroenterol Motil; 2024 Aug 01; 36(8):e14819. PubMed ID: 38816956
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
    Abell TL, Kuo B, Esfandyari T, Pfeifer ND, Grimaldi M, Renzulli C, Tacchi R, Zhou K, Barnes CN, Nguyen DD, Nguyen L, Talley NJ, McCallum R.
    Neurogastroenterol Motil; 2023 Apr 01; 35(4):e14523. PubMed ID: 36624727
    [Abstract] [Full Text] [Related]

  • 18. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
    Ejskjaer N, Vestergaard ET, Hellström PM, Gormsen LC, Madsbad S, Madsen JL, Jensen TA, Pezzullo JC, Christiansen JS, Shaughnessy L, Kosutic G.
    Aliment Pharmacol Ther; 2009 Jun 01; 29(11):1179-87. PubMed ID: 19298585
    [Abstract] [Full Text] [Related]

  • 19. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.
    Hellström PM, Tack J, Johnson LV, Hacquoil K, Barton ME, Richards DB, Alpers DH, Sanger GJ, Dukes GE.
    Br J Pharmacol; 2016 Jun 01; 173(11):1768-77. PubMed ID: 26924243
    [Abstract] [Full Text] [Related]

  • 20. Effects of ondansetron on symptoms during a gastric emptying study and enteral lipid challenge and on daily symptoms in diabetic gastroenteropathy.
    Varma R, Chakraborty SC, Ramu SK, Burton DD, Deb B, Ryks MD, Feuerhak KJ, Bailey KR, Bharucha AE.
    Neurogastroenterol Motil; 2024 Sep 01; 36(9):e14857. PubMed ID: 38946172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.